scispace - formally typeset
P

Patrick Frosk

Researcher at University of Manitoba

Publications -  25
Citations -  1674

Patrick Frosk is an academic researcher from University of Manitoba. The author has contributed to research in topics: Exome sequencing & Population. The author has an hindex of 14, co-authored 25 publications receiving 1415 citations.

Papers
More filters
Journal ArticleDOI

Utility of whole-exome sequencing for those near the end of the diagnostic odyssey: time to address gaps in care.

TL;DR: The analysis of this dataset showed that these known disease genes were not identified prior to WES enrollment for two key reasons: genetic heterogeneity associated with a clinical diagnosis and atypical presentation of known, clinically recognized diseases.
Journal ArticleDOI

Limb-Girdle Muscular Dystrophy Type 2H Associated with Mutation in TRIM32, a Putative E3-Ubiquitin–Ligase Gene

TL;DR: The mutation in the tripartite-motif-containing gene (TRIM32) that replaces aspartate with asparagine at position 487 appears to be the causative mutation of LGMD2H, which represents a new pathogenic mechanism leading to muscular dystrophy.
Journal ArticleDOI

An siRNA-based functional genomics screen for the identification of regulators of ciliogenesis and ciliopathy genes

Gabrielle Wheway, +79 more
- 13 Jul 2015 - 
TL;DR: A whole-genome siRNA-based reverse genetics screen for defects in biogenesis and/or maintenance of the primary cilium is described and insights into ciliogenesis complexity and roles for unanticipated pathways in human genetic disease are provided.
Journal ArticleDOI

TMEM237 Is Mutated in Individuals with a Joubert Syndrome Related Disorder and Expands the Role of the TMEM Family at the Ciliary Transition Zone

TL;DR: These findings integrate TMEM237/JBTS-14 in a complex interaction network of TZ-associated proteins and reveal a growing contribution of a TZ functional module to the spectrum of ciliopathy phenotypes.
Journal ArticleDOI

Neuropathological, biochemical and molecular findings in a glutaric acidemia type 1 cohort

TL;DR: It is concluded that neuron loss occurs shortly after the encephalopathical crisis and does not progress, and the pathogenesis of selective neuronal loss cannot be explained on the basis of regional genetic and/or metabolic differences.